Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis

Radiology

Volumn 214, Issue 3, 2000, Pages 665-670

  Ge, Yulin ^a   Grossman, Robert I ^a   Udupa, Jayaram K ^a   Wei, Luogang ^a   Mannon, Lois J ^a   Polansky, Marcia ^b   Kolson, Dennis L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Brain, abnormalities; Brain, MR; Magnetic resonance (MR), volume measurement; Sclerosis, multiple

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECURRENT DISEASE;

EID: 0034105546     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.214.3.r00mr30665     Document Type: Article

References (39)

1. Grossman RI, McGowan JC. Perspective of multiple sclerosis. AJNR Am J Neuroradiol 1998; 19:1251-1265.
2. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Multiple Sclerosis 1998; 4:93-98.
3. Edwards MK, Farlow MR, Stevens JC. Multiple sclerosis: MRI and clinical correlations. AJR Am J Roentgenol 1986; 147:571-574.
4. Truyen L, Gheuens J, Van de Vyver FL, Parizel PM, Peersman GV, Martin JJ. Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging protocol. J Neurol Sci 1990; 96:173-182.
5. Khoury SJ, Guttmann CRG, Orav EJ, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994; 44:2120-2124.
6. Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images - lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999; 213:395-399.
7. Rooney WD, Goodkin DF, Schuff N, Meyerhoff DJ, Norman D, Weiner MW. 1H MRSI of normal appearing white matter in multiple sclerosis. Multiple Sclerosis 1997; 3:231-237.
8. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182:483-491. [Erratum: Radiology 1992; 183:878.]
9. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994; 36(suppl):S97-S99.
10. Miller DH, Albert PS, Barkhorf F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39:6-16.
11. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995; 45:478-482.
12. Dawson JW. The histology of multiple sclerosis. Trans Royal Soc Edinburgh 1916; 50: 517-740.
13. Zimmerman HM, Netskey MG. The pathology of multiple sclerosis. Res Publications Assoc Nerv Ment Dis 1950; 28:271-312.
14. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25:315-320.
15. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 1996; 119:2009-2019.
16. Rao SM, Glatt S, Hammeke TA, et al. Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985; 42:678-682.
17. Moseley I. Computed tomography and nuclear magnetic resonance imaging of the brain in multiple sclerosis: a review. Bull Soc Belge Ophthalmol 1983; 208: 63-76.
18. Loizou LA, Rolfe EB, Hewazy H, et al. Cranial computed tomography in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1982; 45:905-912.
19. Barnard RO, Triggs M. Corpus callosum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1974; 37:1259-1264.
20. Dietemann JL, Beigelman C, Rumbach L, et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology 1988; 30:478-480.
21. Thompson AJ. Identification of brain atrophy with MRI in MS. Multiple Sclerosis 1998; 4:257-259.
22. Udupa JK, Samarasekera S. Fuzzy connectedness and object definition: theory, algorithms and applications in image segmentation. Graph Models Image Proc 1996; 33:480-489.
23. Udupa JK, Wei L, Samarasekera S, Miki Y, vanBuchem MA, Grossman RI. Detection and quantification of MS lesions using fuzzy topological principles. Proc SPIE 1996; 2710:81-91.
24. Udupa JK, Odhner D, Samaraskera S, et al. 3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system. Proc SPIE 1994; 2164:58-73.
25. Phillips MD, Grossman RI, Miki Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 1998; 19:1055-1060.
26. Miki Y, Grossman RI, Udupa JK, et al. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Radiology 1999; 210:769-774.
27. van Buchem MA, Udupa JK, McGowan JC, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR 1997; 18:1287-1290.
28. Udupa JK, Wei L, Samasekera S, Miki Y, van Buchem MA, Grossman RI. Multiple sclerosis lesion quantification using fuzzy connectedness principles. IEEE Trans Med Imaging 1997; 16:598-609.
29. van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50:1282-1288.
30. Truyen L, van Waesberghe JH, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996; 47:1469-1476.
31. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995; 45:1684-1690.
32. Giugni E, Pozzilli C, Bastianello S, et al. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. Multiple Sclerosis 1997; 3:221-225.
33. Pfefferbaum A, Mathalon DH, Sullivan EV, et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994; 51:874-887.
34. Double KL, Halliday GM, Kril JJ, et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996; 17:513-521.
35. Molyneux PD, Tubridy N, Parker GJM, et al. The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol 1998; 19:1715-1720.
36. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
37. Ferguson B, Matyxzak MK, Esiri NM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120:393-399.
38. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117:49-58.
39. Lublin FD, Reingold SC, for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46:907-911.